The Role of Cannabis in Migraine Treatment

You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!


Key Questions
  • What is the latest research on medical cannabis and migraine?
  • Why is non-oral administration of migraine medications an important consideration?
  • What are common side effects of medical marijuana?
  • How long does the acute relief from vaporized cannabinoids typically last?
  • What did the research show about the effectiveness of THC alone versus THC plus CBD for treating migraine symptoms like photophobia, phonophobia, and nausea?
  • How does cannabis affect the body when used to treat migraine attacks? Does it need to be used in amounts that cause intoxication to be effective, and what does research say about its physiological effects?
  • Are there any potential drug interactions and safety considerations for medical cannabis?
  • How do we know if we need to go to the emergency room when experiencing side effects, like paranoia? What are some other options?
Interview Notes
Treatments Mentioned
  • Aromatherapy
  • Cannabinoid (THC/CBD)
  • Cannabis (vaporized/edible)
  • CGRP inhibitors
  • Exercise
  • Topiramate (Topamax)
  • Triptans
  • Yoga

Please note: The Migraine World Summit’s aim is to bring you a variety of perspectives and expertise, independent of bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan.

Nathaniel M. Schuster, MD

Associate Clinic Director & Associate Professor
University of California, San Diego Center for Pain Medicine

Dr. Nathaniel Schuster is a headache and pain neurologist and an associate professor and associate clinic director at the University of California San Diego Center for Pain Medicine. He received the Migraine Research Foundation 2018 Impact Award to perform the first placebo-controlled trial of cannabis for acute migraine. He is a section editor for the Neuropathic Pain section of the journal Pain Medicine, the official journal of the American Academy of Pain Medicine. He is also a guest editor of the Pain & Headache: A Continuum issue for the journal Practical Neurology. His research focuses on clinical trials for headache and pain, including cannabinoid research.

Get all the 2025 interviews, videos, audio, transcripts, and more. Why upgrade?

  • Can’t attend live? Watch anytime
  • Prefer reading or listening? Get transcripts and audio
  • Want to dive deeper? Explore the additional footage & resources
  • Need ongoing support? Reference expert advice year-round
  • Lifetime access to 2025, no annual fee
Transform Your Migraine Management Today!

Related Talks for: Day 4 (2025)

Exploring Lidocaine, Ketamine & More for Refractory Migraine

Shivang Joshi, MD, MPH, RPh

Brain Fog: Understanding the Cognitive Impacts of Migraine

Elizabeth (Betsy) Seng, PhD

Helping Loved Ones Understand Migraine: Your Discussion Guide

Hope O’Brien, MD, MBA, FAAN, FAHS

The Coalition For Headache And Migraine Patients (CHAMP) is an organization that provides support to people with headache, migraine and cluster diseases who are often stigmatized and under-served.

Learn more

View more/less

Migraine Buddy is the #1 headache and migraine tracking application. Recommended by the best neurologists in the world, we empower our users to learn and communicate about their condition. Our community of 2.8 million contribute to migraine awareness and research.

Learn more

View more/less

Enjoy a one-page summary of key insights from every interview—save time and quickly grasp the essentials. Get the full details in the complete interviews. Available with a VIP or Boxed Set Pass.

View more/less

Leave a comment


Back to top

Loading...